Literature DB >> 17198083

Interaction of Pneumocystis carinii with dendritic cells and resulting host responses to P. carinii.

Hiroyasu Kobayashi1, Stefan Worgall, Timothy P O'Connor, Ronald G Crystal.   

Abstract

To assess the interaction of Pneumocystis carinii with dendritic cells (DCs), and the consequences of the response of the host immune system to P. carinii antigens when DC are pulsed with P. carinii, murine DC were pulsed with P. carinii, and the resultant P. carinii host responses assessed in vitro and in vivo. P. carinii interacted with murine bone marrow-derived DC in vitro in part via mannose receptors. DC pulsed with P. carinii did not demonstrate increased expression of the cell surface markers MHC II, CD40, CD54, CD80 (B7.1), and CD86 (B7.2). The release of interleukin (IL)-4 was increased, but there was no increase in the release of interleukin (IL)-12p40, IL-10, tumor necrosis factor-alpha, IL-6, and nitrite compared with naive DC. In vivo administration of DC pulsed with P. carinii induced a P. carinii-specific response, generating CD4+ cells that proliferated and released IL-4, but not interferon-gamma, in response to P. carinii-pulsed DC in vitro. In vivo administration of DC pulsed with P. carinii also induced P. carinii-specific immunoglobulin (Ig)G1, IgG2a, and IgG2b, but not IgG3, antibodies in serum, and lung lavage fluid. Finally, CD4+ depleted mice immunized with DC pulsed with P. carinii demonstrated suppression of lung growth of P. carinii after intratracheal challenge with P. carinii at 3 and 16 weeks after immunization. These observations provide insight into DC-P. carinii interactions, and support the concept that a vaccine that includes DC pulsed with P. carinii can mount a humoral and T helper 2-type cellular response to P. carinii sufficient to suppress the growth of P. carinii in the lung.

Entities:  

Mesh:

Year:  2007        PMID: 17198083     DOI: 10.1097/01.cji.0000211314.13492.64

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  7 in total

Review 1.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

2.  The Major Surface Glycoprotein of Pneumocystis murina Does Not Activate Dendritic Cells.

Authors:  Monica Sassi; Geetha Kutty; Gabriela A Ferreyra; Lisa R Bishop; Yueqin Liu; Ju Qiu; Da Wei Huang; Joseph A Kovacs
Journal:  J Infect Dis       Date:  2018-10-05       Impact factor: 5.226

Review 3.  New advances in understanding the host immune response to Pneumocystis.

Authors:  J Claire Hoving; Jay K Kolls
Journal:  Curr Opin Microbiol       Date:  2017-11-12       Impact factor: 7.934

4.  Pneumocystis infection in an immunocompetent host can promote collateral sensitization to respiratory antigens.

Authors:  Steve D Swain; Nicole Meissner; Soo Han; Allen Harmsen
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

5.  Plasma IL-6/IL-10 Ratio and IL-8, LDH, and HBDH Level Predict the Severity and the Risk of Death in AIDS Patients with Pneumocystis Pneumonia.

Authors:  Jia Sun; Junwei Su; Yirui Xie; Michael T Yin; Ying Huang; Lijun Xu; Qihui Zhou; Biao Zhu
Journal:  J Immunol Res       Date:  2016-08-07       Impact factor: 4.818

6.  A Pilot Study of Echinocandin Combination with Trimethoprim/Sulfamethoxazole and Clindamycin for the Treatment of AIDS Patients with Pneumocystis Pneumonia.

Authors:  Mengyan Wang; Guanjing Lang; Ying Chen; Caiqin Hu; Yongzheng Guo; Ran Tao; Xiaotian Dong; Biao Zhu
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

7.  Immunization with Pneumocystis carinii A121-85 antigen activates immune function against P. carinii.

Authors:  Tong Tong; Zhongxin Wang; Yuanhong Xu; Jilu Shen
Journal:  BMC Immunol       Date:  2021-06-27       Impact factor: 3.594

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.